Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury

Area of Science:

• Immunology
• Pharmacology
• Toxicology

Background:

• Idiosyncratic adverse drug reactions (IADRs) are diverse, unpredictable, and rare toxicities posing significant challenges in prediction, diagnosis, and treatment.
• The adaptive immune system, through human leukocyte antigen (HLA) risk alleles and drug-induced lymphocyte proliferation, plays a role in IADR pathogenesis.
• Innate immune responses, triggered by drug-induced stress and neoantigen formation, are also implicated, influenced by drug and patient-specific factors.

Purpose of the Study:

• To provide a comprehensive overview of the clinical profile, underlying mechanisms, and risk factors associated with IADRs.
• To explore emerging approaches for studying IADRs, with a specific focus on idiosyncratic drug-induced liver injury (IDILI).

Main Methods:

• Review of existing literature on IADRs, encompassing clinical characteristics, immunological findings, and drug/patient-specific influences.
• Synthesis of evidence supporting the roles of adaptive and innate immune systems in IADR development.
• Focus on methodologies for investigating IDILI.

Main Results:

• Evidence supports a dual role for adaptive immunity (HLA associations, lymphocyte responses) and innate immunity (drug stress, neoantigens) in IADR pathogenesis.
• Both drug properties and patient intrinsic factors significantly influence the development of IADRs.
• Specific focus on idiosyncratic drug-induced liver injury highlights its complexity.

Conclusions:

• IADRs result from a complex interplay of drug properties, patient factors, and both adaptive and innate immune system activation.
• Further research into these mechanisms is essential for improving the prediction, diagnosis, and treatment of IADRs, particularly IDILI.
• Novel study approaches are needed to unravel the complexities of these rare adverse drug reactions.